Hydroxynorketamine

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameHydroxynorketamine
Drug Alias Name6-hydroxynorketamine(2R,6R)-Hydroxynorketamine hydrochloride(2R,6R)-HydroxynorketamineRR-HNK
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepressive Disorder +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute On Aging (NIA)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthRush University Medical CenterNational Institute Of Mental Health (Nimh)
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepressive Disorder +[9] 
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A